JPMorgan analyst Chris Schott downgraded Valeant Pharmaceutical to Underweight while raising his price target for the shares to $12 from $10. Underweight is JPMorgan's lowest...
Elliott Advisors, which advises funds that collectively hold an economic interest in NXP Semiconductors N.V. (NXPI) of approximately 6%, today released the UBS Valuation Report...
Apple (AAPL) announced that Finisar (FNSR) will receive $390M from its $1B Advanced Manufacturing Fund. "The award will enable Finisar to exponentially increase its R&D...
In a regulatory filing, Teva said that on December 12, Dr. Yitzhak Peterburg, a member of the Board of Directors of Teva Pharmaceutical Industries, and...